Quality-Of-Life Changes In Women With Female Androgenetic Alopecia Treated With A Methylsulfonylmethane-Containing 5-Alpha-Reductase Inhibitor: A Clinical Practice Study

    September 2026 in “ Actas Dermo-Sifiliográficas ”
    A. Guerra-Tapia, J. Ferrando-Barberá, A. Buendía-Eisman … E. González-Guerra
    Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

    We don't know much about this study yet.

    Read the full study on sciencedirect.com →
    Discuss this study in the Community →